| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 58.39B | 59.48B | 57.99B | 58.60B | 48.70B | 40.67B |
| Gross Profit | 22.75B | 24.39B | 22.45B | 24.21B | 21.27B | 18.01B |
| EBITDA | 15.37B | 15.98B | 15.14B | 17.32B | 15.80B | 13.38B |
| Net Income | 8.31B | 8.94B | 8.30B | 10.78B | 10.43B | 8.29B |
Balance Sheet | ||||||
| Total Assets | 95.75B | 105.63B | 98.06B | 98.83B | 72.49B | 64.99B |
| Cash, Cash Equivalents and Short-Term Investments | 21.67B | 25.53B | 21.88B | 17.89B | 22.46B | 21.16B |
| Total Debt | 11.75B | 11.53B | 12.34B | 12.67B | 1.79B | 387.00M |
| Total Liabilities | 22.41B | 26.21B | 24.19B | 28.88B | 13.12B | 12.33B |
| Stockholders Equity | 73.34B | 79.42B | 73.86B | 69.95B | 59.37B | 52.66B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 8.17B | 7.15B | -5.83B | 3.58B | 10.59B |
| Operating Cash Flow | 0.00 | 15.13B | 14.18B | 5.64B | 6.06B | 11.95B |
| Investing Cash Flow | 0.00 | -5.88B | -6.81B | -16.20B | -573.00M | -1.55B |
| Financing Cash Flow | 0.00 | -5.32B | -3.96B | 5.32B | -2.79B | -1.71B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥6.71B | 9.00 | ― | 2.80% | 6.47% | 2.73% | |
81 Outperform | ¥26.48B | 4.94 | ― | 0.72% | 6.51% | 3.68% | |
80 Outperform | ¥227.93B | 18.03 | ― | 2.50% | 2.57% | 9.10% | |
71 Outperform | ¥108.55B | 14.92 | ― | 4.64% | 1.98% | -17.68% | |
69 Neutral | ¥124.14B | 15.63 | ― | 3.77% | -2.59% | 9.56% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
50 Neutral | ¥7.73B | 164.26 | ― | 1.65% | 3.81% | ― |